Cargando…

Screening for inherited metabolic disorders in patients with Familial Mediterranean Fever

Detalles Bibliográficos
Autores principales:	Kiykim, E, Aktuglu-Zeybek, AC, Barut, K, Zubarioglu, T, Cansever, MS, Aydin, A, Kasapcopur, O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599953/ http://dx.doi.org/10.1186/1546-0096-13-S1-P97

Ejemplares similares

Screening of free carnitine and acyl-carnitine status in patients with Familial Mediterranean Fever
por: Kiykim, E, et al.
Publicado: (2015)

Evaluation of plasma carnitine status in patients diagnosed with juvenile idiopathic arthritis
por: AKTUĞLU ZEYBEK, Ayşe Ciğdem, et al.
Publicado: (2022)

Maternal Inborn Errors of Metabolism Detected in Expanded Newborn Metabolic Screening
por: Tin, Oğuzhan, et al.
Publicado: (2023)

Articular involvement in childhood Familial Mediterranean Fever
por: Barut, K, et al.
Publicado: (2015)

Increased frequency of psoriasis in the families of subjects with childhood Familial Mediterranean Fever
por: Barut, Kenan, et al.
Publicado: (2014)

Clinical and neuroradiological approach to fucosidosis in a child with atypical presentation
por: Zubarioglu, Tanyel, et al.
Publicado: (2015)

A Methionine-Portioning-Based Medical Nutrition Therapy with Relaxed Fruit and Vegetable Consumption in Patients with Pyridoxine-Nonresponsive Cystathionine-β-Synthase Deficiency
por: Uygur, Esma, et al.
Publicado: (2023)

Long-term N-carbamylglutamate treatment of hyperammonemia in patients with classic organic acidemias
por: Kiykim, Ertugrul, et al.
Publicado: (2021)

Analysis of Biotinidase Activity in Serum by Digital Imaging Colorimetry Detection
por: Destanoğlu, Orhan, et al.
Publicado: (2023)

An Overview of Acute Hepatic Porphyrias: Clinical Implications, Diagnostic Approaches, and Management Strategies
por: Zübarioğlu, Tanyel, et al.
Publicado: (2023)

Development of focal segmental glomerulosclerosis in a patient with Familial Mediterranean Fever resistant to colchicine therapy under treatment with Canakinumab
por: Barut, K, et al.
Publicado: (2015)

Familial Mediterranean Fever in childhood: a single center experience
por: Barut, K, et al.
Publicado: (2015)

Evaluation of the effect of chenodeoxycholic acid treatment on skeletal system findings in patients with cerebrotendinous xanthomatosis
por: Zübarioğlu, Tanyel, et al.
Publicado: (2019)

Evaluation of clinical, neuroradiologic, and genotypic features of patients with L-2-hydroxyglutaric aciduria
por: Zübarioğlu, Tanyel, et al.
Publicado: (2020)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up
por: Polat, Adem, et al.
Publicado: (2014)

Familial Mediterranean Fever in older children
por: Özdel, Semanur, et al.
Publicado: (2014)

The role of genotype in Familial Mediterranean Fever
por: Özdel, Semanur, et al.
Publicado: (2014)

Comorbidities in patients with Familial Mediterranean Fever
por: Balci-Peynircioğlu, B, et al.
Publicado: (2015)

Neonatal onset Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

The association of Familial Mediterranean Fever and cryptogenic cirrhosis
por: Baskin, E, et al.
Publicado: (2008)

Musculoskeletal complaints in patients with Familial Mediterranean Fever
por: Özçakar, ZB, et al.
Publicado: (2015)

Familial Mediterranean Fever associated diseases in children
por: Özçakar, ZB, et al.
Publicado: (2015)

Quality of life in children with familial Mediterranean fever
por: Öztürk, Ö, et al.
Publicado: (2015)

Familial Mediterranean Fever and Human autoinflammatory diseases
por: Hovhannisyan, L
Publicado: (2015)

Challenging case of Familial Mediterranean Fever and its management
por: Al Hosani, A, et al.
Publicado: (2015)

PReS-FINAL-2195: The comparison of the efficacy of once and twice daily dosage of colchicine in pediatric patients with Familial Mediterranean Fever
por: Polat, A, et al.
Publicado: (2013)

Increased prevalence of attention deficit hyperactivity disorder in children with Familial Mediterranean Fever
por: Lavi, E, et al.
Publicado: (2015)

Familial Mediterranean Fever (FMF) before the age of one year
por: Delion, F, et al.
Publicado: (2008)

Risk factors for subclinical inflammation in children with familial mediterranean fever
por: Soylu, Alper, et al.
Publicado: (2014)

Evidence based recommendations for genetic diagnosis of Familial Mediterranean Fever
por: Giancane, Gabriella, et al.
Publicado: (2014)

L-ficolin and H-ficolin in patients with Familial Mediterranean fever
por: Mkrtchyan, G, et al.
Publicado: (2015)

Increased Frequency of Febrile Seizures in Two Periodic Fever Syndromes: Familial Mediterranean Fever and PFAPA Syndrome
por: Kılıç, Hüseyin, et al.
Publicado: (2022)

Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)
por: Vitale, A, et al.
Publicado: (2008)

Clinical and demographic characteristics of children with familial mediterranean fever in Central Anatolia
por: Akin, Onur, et al.
Publicado: (2011)

PReS-FINAL-2242: Familial Mediterranean Fever - first experiences in Slovakia
por: Dallos, T, et al.
Publicado: (2013)

Indications and efficacy of canakinumab in Familial Mediterranean Fever: report of three cases
por: Tsinti, Maria, et al.
Publicado: (2014)

The patient experience of Colchicine Resistant-Familial Mediterranean Fever (cr-FMF)
por: Dandekar, P, et al.
Publicado: (2015)

Evaluation of familial mediterranean fever patients: a single center experience
por: Gulez, P, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fj3vbmjnc233p40lnnbeiqhfu3